著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Daniel V T Catenacci and Niall C Tebbutt and Irina Davidenko and André M Murad and Salah-Eddin Al-Batran and David H Ilson and Sergei Tjulandin and Evengy Gotovkin and Boguslawa Karaszewska and Igor Bondarenko and Mohamedtaki A Tejani and Anghel A Udrea and Mustapha Tehfe and Ferdinando De Vita and Cheryl Turkington and Rui Tang and Agnes Ang and Yilong Zhang and Tien Hoang and Roger Sidhu and David Cunningham,"Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial",The Lancet Oncology,1470-2045,Elsevier BV,2017-11,18,11,1467-1482,https://cir.nii.ac.jp/crid/1362262943834608512,https://doi.org/10.1016/s1470-2045(17)30566-1